0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

biosciences/Malar J


55 results

MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors.Tuwei M, Karisa J, Wanjiku C, Kiuru C, Ondieki Z, Odongo T, Mure F, Otieno B, Meli P, Okoko M, Bartilol B, Gona R, Constantino L, Cole G, Anastácio T, Armazia R, Alves C, Rui P, Ramaita E, Rono M, Candrinho B, Mwangangi J, Mbogo C, Charlwood D, Saute F, Rabinovich R, Chaccour C, Maia MF
Malar J, (2025). 24:284

Phenotypic and genotypic insecticide resistance profiles of main malaria vectors in Kwale county, coastal Kenya.Okoko M, Karisa J, Gona R, Odongo T, Otieno B, Yaa F, Bartilol B, Meli P, Ondieki Z, Tuwei M, Wanjiku C, Shee F, Chaccour C, Kiuru C, Maia MF
Malar J, (2025). 24:191

Stable Plasmodium falciparum merozoite surface protein-1 allelic diversity despite decreasing parasitaemia in children with multiple malaria infections.Yaa RM, Kimenyi KM, Palasciano HA, Obiero G, Ochola-Oyier LI
Malar J, (2025). 24:136

Multiple insecticide resistance in Anopheles funestus from Mopeia, Central Mozambique.Kiuru C, Constantino L, Cole G, Karisa J, Wanjiku C, Okoko M, Candrinho B, Saute F, Rabinovich NR, Chaccour C, Maia MF
Malar J, (2025). 24:81

Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.Onyango T, Nuru K, Kazungu K, Wangari W, Chaccour C, Regina Rabinovich N, Mwangangi J, Maia M, Jones C
Malar J, (2025). 24:79

The Anopheles coluzzii range extends into Kenya: detection, insecticide resistance profiles and population genetic structure in relation to conspecific populations in West and Central Africa.Kamau L, Bennett KL, Ochomo E, Herren J, Agumba S, Otieno S, Omoke D, Matoke-Muhia D, Mburu D, Mwangangi J, Ramaita E, Juma EO, Mbogo C, Barasa S, Miles A
Malar J, (2024). 23:122

A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors.Ominde KM, Kamau Y, Karisa J, Muturi MN, Kiuru C, Wanjiku C, Babu L, Yaah F, Tuwei M, Musani H, Ondieki Z, Muriu S, Mwangangi J, Chaccour C, Maia MF
Malar J, (2023). 22:291

Determinants of utilization of malaria preventive measures during pregnancy among women aged 15 to 49 years in Kenya: an analysis of the Malaria Indicator Survey 2020.Mkubwa B, Kagura J, Chirwa T, Ibisomi L, Kinyanjui S
Malar J, (2022). 21:398

Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.Mwai K, Nkumama I, Thairu A, Mburu J, Odera D, Kimathi R, Nyamako L, Tuju J, Kinyanjui S, Musenge E, Osier F
Malar J, (2022). 21:326

Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018.Kimenyi KM, Wamae K, Ngoi JM, de Laurent ZR, Ndwiga L, Osoti V, Obiero G, Abdi AI, Bejon P, Ochola-Oyier LI
Malar J, (2022). 21:192

Factors influencing health workers' compliance with outpatient malaria 'test and treat' guidelines during the plateauing performance phase in Kenya, 2014-2016.Amboko B, Stepniewska K, Machini B, Bejon P, Snow RW, Zurovac D
Malar J, (2022). 21:68

Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.Mzumara G, Leopold S, Marsh K, Dondorp A, Ohuma EO, Mukaka M
Malar J, (2021). 20:282

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations.Ndwiga L, Osoti V, Ochwedo KO, Wamae K, Bejon P, Rayner JC, Githinji G, Ochola-Oyier LI
Malar J, (2021). 20:278

Determinants of the varied profiles of Plasmodium falciparum infections among infants living in Kintampo, Ghana.Botwe AK, Oppong FB, Gyaase S, Owusu-Agyei S, Asghar M, Asante KP, Farnert A, Osier F
Malar J, (2021). 20:240

Spatial-temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast.Kamau A, Mtanje G, Mataza C, Bejon P, Snow RW
Malar J, (2021). 20:227

Building momentum for malaria vaccine research and development: key considerations.Chitnis CE, Schellenberg D, Vekemans J, Asturias EJ, Bejon P, Collins KA, Crabb BS, Herrera S, Laufer M, Rabinovich NR, Roestenberg M, Shearley A, Tinto H, Wentworth M, O'Brien K, Alonso P
Malar J, (2020). 19:421

Trends in health workers' compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010-2016.Amboko B, Stepniewska K, Macharia PM, Machini B, Bejon P, Snow RW, Zurovac D
Malar J, (2020). 19:406

Evaluating the impact of larviciding with Bti and community education and mobilization as supplementary integrated vector management interventions for malaria control in Kenya and Ethiopia.Mutero CM, Okoyo C, Girma M, Mwangangi J, Kibe L, Ng'ang'a P, Kussa D, Diiro G, Affognon H, Mbogo CM
Malar J, (2020). 19:390

Evaluating effectiveness of screening house eaves as a potential intervention for reducing indoor vector densities and malaria prevalence in Nyabondo, western Kenya.Ng'ang'a PN, Okoyo C, Mbogo C, Mutero CM
Malar J, (2020). 19:341

Malaria infection, disease and mortality among children and adults on the coast of Kenya.Kamau A, Mtanje G, Mataza C, Mwambingu G, Mturi N, Mohammed S, Ong'ayo G, Nyutu G, Nyaguara A, Bejon P, Snow RW
Malar J, (2020). 19:210